Cargando…
Rifapentine Polylactic Acid Sustained-Release Microsphere Complex for Spinal Tuberculosis Therapy: Preparation, in vitro and in vivo Studies
PURPOSE: Spinal tuberculosis has been a common clinical extrapulmonary tuberculosis in recent years. The general anti-tuberculosis drug treatment cycle is long, with unsatisfactory efficacy. This study focused on the preparation and evaluation of rifapentine polylactic acid sustained-release microsp...
Autores principales: | Wang, Zhen, Maimaitiaili, Abulikemu, Wang, Tengfei, Song, Xinghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132576/ https://www.ncbi.nlm.nih.gov/pubmed/34025123 http://dx.doi.org/10.2147/IDR.S304864 |
Ejemplares similares
-
Drug Release Characteristics and Tissue Distribution of Rifapentine Polylactic Acid Sustained-Release Microspheres in Rabbits after Paravertebral Implantation
por: Zhang, Zheng, et al.
Publicado: (2016) -
Rifapentine-linezolid-loaded PLGA microspheres for interventional therapy of cavitary pulmonary tuberculosis: preparation and in vitro characterization
por: Huang, Jieyun, et al.
Publicado: (2017) -
Development of dual delivery antituberculotic system containing rifapentine microspheres and adipose stem cells seeded in hydroxyapatite/tricalcium phosphate
por: Liang, Qiuzhen, et al.
Publicado: (2019) -
Preparation and in vivo/in vitro characterization of Ticagrelor PLGA sustained-release microspheres for injection
por: Hao, Linkun, et al.
Publicado: (2021) -
Rifapentine-Proliposomes for Inhalation: In Vitro and In Vivo Toxicity
por: Patil-Gadhe, Arpana A., et al.
Publicado: (2014)